[Xolair is approved in the USA and the EU].
Kärnell
Anders
A
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D017277:Drug Approval; D005062:European Union; D006801:Humans; D000069444:Omalizumab; D014481:United States
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab